268 related articles for article (PubMed ID: 27799202)
1. Acquisition of Carbapenem Resistance by Plasmid-Encoded-AmpC-Expressing Escherichia coli.
van Boxtel R; Wattel AA; Arenas J; Goessens WH; Tommassen J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799202
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.
Goessens WH; van der Bij AK; van Boxtel R; Pitout JD; van Ulsen P; Melles DC; Tommassen J
Antimicrob Agents Chemother; 2013 Aug; 57(8):3941-9. PubMed ID: 23733461
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
[TBL] [Abstract][Full Text] [Related]
4. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E
J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases.
Mammeri H; Guillon H; Eb F; Nordmann P
Antimicrob Agents Chemother; 2010 Nov; 54(11):4556-60. PubMed ID: 20733047
[TBL] [Abstract][Full Text] [Related]
6. Influence of acquired β-lactamases on the evolution of spontaneous carbapenem resistance in Escherichia coli.
Adler M; Anjum M; Andersson DI; Sandegren L
J Antimicrob Chemother; 2013 Jan; 68(1):51-9. PubMed ID: 22977158
[TBL] [Abstract][Full Text] [Related]
7. The plasmid-encoded transcription factor ArdK contributes to the repression of the IMP-6 metallo-β-lactamase gene blaIMP-6, leading to a carbapenem-susceptible phenotype in the blaIMP-6-positive Escherichia coli strain A56-1S.
Segawa T; Sekizuka T; Suzuki S; Shibayama K; Matsui M; Kuroda M
PLoS One; 2018; 13(12):e0208976. PubMed ID: 30533034
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
Pires J; Taracila M; Bethel CR; Doi Y; Kasraian S; Tinguely R; Sendi P; Bonomo RA; Endimiani A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7483-8. PubMed ID: 26392491
[TBL] [Abstract][Full Text] [Related]
9. Porin deficiency or plasmid copy number increase mediated carbapenem-resistant
Xiang G; Zhao Z; Zhang S; Cai Y; He Y; Zeng J; Chen C; Huang B
Emerg Microbes Infect; 2024 Dec; 13(1):2352432. PubMed ID: 38712634
[TBL] [Abstract][Full Text] [Related]
10. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
[TBL] [Abstract][Full Text] [Related]
11. Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan.
Ma L; Siu LK; Lin JC; Wu TL; Fung CP; Wang JT; Lu PL; Chuang YC
BMC Infect Dis; 2013 Dec; 13():599. PubMed ID: 24354657
[TBL] [Abstract][Full Text] [Related]
12. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
Mammeri H; Nordmann P; Berkani A; Eb F
FEMS Microbiol Lett; 2008 May; 282(2):238-40. PubMed ID: 18371063
[TBL] [Abstract][Full Text] [Related]
13. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
15. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
16. High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain.
Castellanos LR; Donado-Godoy P; León M; Clavijo V; Arevalo A; Bernal JF; Timmerman AJ; Mevius DJ; Wagenaar JA; Hordijk J
PLoS One; 2017; 12(1):e0170777. PubMed ID: 28125687
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of Two
Feng Y; Liu L; McNally A; Zong Z
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439976
[TBL] [Abstract][Full Text] [Related]
18. Host-Specific Patterns of Genetic Diversity among IncI1-Iγ and IncK Plasmids Encoding CMY-2 β-Lactamase in Escherichia coli Isolates from Humans, Poultry Meat, Poultry, and Dogs in Denmark.
Hansen KH; Bortolaia V; Nielsen CA; Nielsen JB; Schønning K; Agersø Y; Guardabassi L
Appl Environ Microbiol; 2016 Aug; 82(15):4705-14. PubMed ID: 27235431
[TBL] [Abstract][Full Text] [Related]
19. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
20. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
Odeh R; Kelkar S; Hujer AM; Bonomo RA; Schreckenberger PC; Quinn JP
Clin Infect Dis; 2002 Jul; 35(2):140-5. PubMed ID: 12087519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
